Skip to Main Content

Paper Details

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
Cancer
2
2023
Author NameAffiliation
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2